By regulating the influence of sEVs on CD8 + T cells, NK cells, etc., and elucidating sEV-mediated immune evasion mechanisms (such as the transfer of PD-L1 and NKG2D ligands), more potent immunotherapeutic approaches for PCa could be devised. This evidence concerns the gene KLRK1 and posterior cortical atrophy.